Movatterモバイル変換


[0]ホーム

URL:


GB1147210A - Improvements in or relating to vitamins - Google Patents

Improvements in or relating to vitamins

Info

Publication number
GB1147210A
GB1147210AGB2835266AGB2835266AGB1147210AGB 1147210 AGB1147210 AGB 1147210AGB 2835266 AGB2835266 AGB 2835266AGB 2835266 AGB2835266 AGB 2835266AGB 1147210 AGB1147210 AGB 1147210A
Authority
GB
United Kingdom
Prior art keywords
water
vitamin
dispersion
dispersing medium
dispersing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2835266A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastman Kodak Co
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak CofiledCriticalEastman Kodak Co
Publication of GB1147210ApublicationCriticalpatent/GB1147210A/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

1,147,210. Vitamin beadlets. EASTMAN KODAK CO. 24 June, 1966 [30 June, 1965], No. 28352/66. Heading A5B. A process for making a dry, free flowing, finely divided, fat-soluble vitamin-active product, comprises (1) preparing a colloidal solution of cold water dispersible, non-gelling colloid material and water; (2) dispersing in said colloidal solution a water insoluble, fat soluble vitamin active composition to form a first dispersion; (3) dispersing the latter in a water immiscible liquid dispersing medium to form a second dispersion; (4) extracting water at - 10 to 0‹C from the latter with a water extraction agent until droplets of the first dispersion solidify to form particles; (5) separating the latter from the dispersing medium and water extraction agent at -10 to 0‹C; and (6) removing residual moisture from the solid particles. Lecithin may be added as a stabilising agent to the second dispersion. The colloid material may be gum acacia, gum ghatti, amylopectin, pre-gelatinised and thin boiling starches, substituted starches, e.g. corn starch which has 'been partially reacted with octenyl succinic anhydride, or mixtures thereof. Water soluble, edible, plasticizers e.g. glucose, sucrose, dextrose, lactose, and corn syrup may 'be used with the colloid material. The vitamin-active composition consists of at least one water insoluble, fat soluble, vitamin active compound e.g. vitamin A, D, E, and K compounds. The compounds may be in solution or suspended in oil. The vitamin active composition may 'be liquid, solid, or a mixture of solids and liquid. An antioxidant may be incorporated in the vitamin active composition. The water immiscible dispersing medium may be mineral oil. Specified water extracting agents are methanol, ethanol, isopropanol, acetone, methyl ethyl ketone, 1,4-dioxan, pyridine, and mixtures thereof. The particles may be separated from the dispersing medium by filtration and washed with additional water extraction agent and then with a solvent for the dispersing medium e.g. hexane when the medium is mineral oil. Residual moisture may be removed by air drying, for instance, using a fluidised bed.
GB2835266A1965-06-301966-06-24Improvements in or relating to vitaminsExpiredGB1147210A (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US46862765A1965-06-301965-06-30

Publications (1)

Publication NumberPublication Date
GB1147210Atrue GB1147210A (en)1969-04-02

Family

ID=23860573

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB2835266AExpiredGB1147210A (en)1965-06-301966-06-24Improvements in or relating to vitamins

Country Status (1)

CountryLink
GB (1)GB1147210A (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4262017A (en)*1978-05-221981-04-14Basf AktiengesellschaftPreparation of a vitamin E dry powder
FR2468364A1 (en)*1979-10-311981-05-08Tanabe Seiyaku Co PROCESS FOR THE PREPARATION OF ETHYLCELLULOSE MICROCAPSULES CONTAINING A PHARMACEUTICALLY ACTIVE COMPOUND
US5234695A (en)*1990-07-241993-08-10Eastman Kodak CompanyWater dispersible vitamin E composition
WO2011095314A2 (en)2010-02-032011-08-11Grünenthal GmbHPreparation of a powdery pharmaceutical composition by means of an extruder
US8075872B2 (en)2003-08-062011-12-13Gruenenthal GmbhAbuse-proofed dosage form
US8114383B2 (en)2003-08-062012-02-14Gruenenthal GmbhAbuse-proofed dosage form
US8114384B2 (en)2004-07-012012-02-14Gruenenthal GmbhProcess for the production of an abuse-proofed solid dosage form
US8192722B2 (en)2003-08-062012-06-05Grunenthal GmbhAbuse-proof dosage form
US8383152B2 (en)2008-01-252013-02-26Gruenenthal GmbhPharmaceutical dosage form
US8722086B2 (en)2007-03-072014-05-13Gruenenthal GmbhDosage form with impeded abuse
WO2015078891A1 (en)2013-11-262015-06-04Farmaceutici Formenti S.P.A.Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9161917B2 (en)2008-05-092015-10-20Grünenthal GmbHProcess for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US9636303B2 (en)2010-09-022017-05-02Gruenenthal GmbhTamper resistant dosage form comprising an anionic polymer
US9655853B2 (en)2012-02-282017-05-23Grünenthal GmbHTamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US9675610B2 (en)2002-06-172017-06-13Grünenthal GmbHAbuse-proofed dosage form
US9737490B2 (en)2013-05-292017-08-22Grünenthal GmbHTamper resistant dosage form with bimodal release profile
US9855263B2 (en)2015-04-242018-01-02Grünenthal GmbHTamper-resistant dosage form with immediate release and resistance against solvent extraction
US9872835B2 (en)2014-05-262018-01-23Grünenthal GmbHMultiparticles safeguarded against ethanolic dose-dumping
US9913814B2 (en)2014-05-122018-03-13Grünenthal GmbHTamper resistant immediate release capsule formulation comprising tapentadol
US9925146B2 (en)2009-07-222018-03-27Grünenthal GmbHOxidation-stabilized tamper-resistant dosage form
US10058548B2 (en)2003-08-062018-08-28Grünenthal GmbHAbuse-proofed dosage form
US10064945B2 (en)2012-05-112018-09-04Gruenenthal GmbhThermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10080721B2 (en)2009-07-222018-09-25Gruenenthal GmbhHot-melt extruded pharmaceutical dosage form
US10154966B2 (en)2013-05-292018-12-18Grünenthal GmbHTamper-resistant dosage form containing one or more particles
US10201502B2 (en)2011-07-292019-02-12Gruenenthal GmbhTamper-resistant tablet providing immediate drug release
US10300141B2 (en)2010-09-022019-05-28Grünenthal GmbHTamper resistant dosage form comprising inorganic salt
US10335373B2 (en)2012-04-182019-07-02Grunenthal GmbhTamper resistant and dose-dumping resistant pharmaceutical dosage form
US10624862B2 (en)2013-07-122020-04-21Grünenthal GmbHTamper-resistant dosage form containing ethylene-vinyl acetate polymer
US10695297B2 (en)2011-07-292020-06-30Grünenthal GmbHTamper-resistant tablet providing immediate drug release
US10729658B2 (en)2005-02-042020-08-04Grünenthal GmbHProcess for the production of an abuse-proofed dosage form
US10842750B2 (en)2015-09-102020-11-24Grünenthal GmbHProtecting oral overdose with abuse deterrent immediate release formulations
US11224576B2 (en)2003-12-242022-01-18Grünenthal GmbHProcess for the production of an abuse-proofed dosage form
US11844865B2 (en)2004-07-012023-12-19Grünenthal GmbHAbuse-proofed oral dosage form

Cited By (45)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4262017A (en)*1978-05-221981-04-14Basf AktiengesellschaftPreparation of a vitamin E dry powder
FR2468364A1 (en)*1979-10-311981-05-08Tanabe Seiyaku Co PROCESS FOR THE PREPARATION OF ETHYLCELLULOSE MICROCAPSULES CONTAINING A PHARMACEUTICALLY ACTIVE COMPOUND
US5234695A (en)*1990-07-241993-08-10Eastman Kodak CompanyWater dispersible vitamin E composition
US10369109B2 (en)2002-06-172019-08-06Grünenthal GmbHAbuse-proofed dosage form
US9675610B2 (en)2002-06-172017-06-13Grünenthal GmbHAbuse-proofed dosage form
US9629807B2 (en)2003-08-062017-04-25Grünenthal GmbHAbuse-proofed dosage form
US8114383B2 (en)2003-08-062012-02-14Gruenenthal GmbhAbuse-proofed dosage form
US8192722B2 (en)2003-08-062012-06-05Grunenthal GmbhAbuse-proof dosage form
US8309060B2 (en)2003-08-062012-11-13Grunenthal GmbhAbuse-proofed dosage form
US10130591B2 (en)2003-08-062018-11-20Grünenthal GmbHAbuse-proofed dosage form
US10058548B2 (en)2003-08-062018-08-28Grünenthal GmbHAbuse-proofed dosage form
US8420056B2 (en)2003-08-062013-04-16Grunenthal GmbhAbuse-proofed dosage form
US8075872B2 (en)2003-08-062011-12-13Gruenenthal GmbhAbuse-proofed dosage form
US11224576B2 (en)2003-12-242022-01-18Grünenthal GmbHProcess for the production of an abuse-proofed dosage form
US11844865B2 (en)2004-07-012023-12-19Grünenthal GmbHAbuse-proofed oral dosage form
US8114384B2 (en)2004-07-012012-02-14Gruenenthal GmbhProcess for the production of an abuse-proofed solid dosage form
US8323889B2 (en)2004-07-012012-12-04Gruenenthal GmbhProcess for the production of an abuse-proofed solid dosage form
US10729658B2 (en)2005-02-042020-08-04Grünenthal GmbHProcess for the production of an abuse-proofed dosage form
US10675278B2 (en)2005-02-042020-06-09Grünenthal GmbHCrush resistant delayed-release dosage forms
US8722086B2 (en)2007-03-072014-05-13Gruenenthal GmbhDosage form with impeded abuse
US8383152B2 (en)2008-01-252013-02-26Gruenenthal GmbhPharmaceutical dosage form
US9750701B2 (en)2008-01-252017-09-05Grünenthal GmbHPharmaceutical dosage form
US9161917B2 (en)2008-05-092015-10-20Grünenthal GmbHProcess for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet
US10493033B2 (en)2009-07-222019-12-03Grünenthal GmbHOxidation-stabilized tamper-resistant dosage form
US9925146B2 (en)2009-07-222018-03-27Grünenthal GmbHOxidation-stabilized tamper-resistant dosage form
US10080721B2 (en)2009-07-222018-09-25Gruenenthal GmbhHot-melt extruded pharmaceutical dosage form
US9579285B2 (en)2010-02-032017-02-28Gruenenthal GmbhPreparation of a powdery pharmaceutical composition by means of an extruder
WO2011095314A2 (en)2010-02-032011-08-11Grünenthal GmbHPreparation of a powdery pharmaceutical composition by means of an extruder
US9636303B2 (en)2010-09-022017-05-02Gruenenthal GmbhTamper resistant dosage form comprising an anionic polymer
US10300141B2 (en)2010-09-022019-05-28Grünenthal GmbHTamper resistant dosage form comprising inorganic salt
US10695297B2 (en)2011-07-292020-06-30Grünenthal GmbHTamper-resistant tablet providing immediate drug release
US10864164B2 (en)2011-07-292020-12-15Grünenthal GmbHTamper-resistant tablet providing immediate drug release
US10201502B2 (en)2011-07-292019-02-12Gruenenthal GmbhTamper-resistant tablet providing immediate drug release
US9655853B2 (en)2012-02-282017-05-23Grünenthal GmbHTamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US10335373B2 (en)2012-04-182019-07-02Grunenthal GmbhTamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en)2012-05-112018-09-04Gruenenthal GmbhThermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10154966B2 (en)2013-05-292018-12-18Grünenthal GmbHTamper-resistant dosage form containing one or more particles
US9737490B2 (en)2013-05-292017-08-22Grünenthal GmbHTamper resistant dosage form with bimodal release profile
US10624862B2 (en)2013-07-122020-04-21Grünenthal GmbHTamper-resistant dosage form containing ethylene-vinyl acetate polymer
US10449547B2 (en)2013-11-262019-10-22Grünenthal GmbHPreparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015078891A1 (en)2013-11-262015-06-04Farmaceutici Formenti S.P.A.Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9913814B2 (en)2014-05-122018-03-13Grünenthal GmbHTamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en)2014-05-262018-01-23Grünenthal GmbHMultiparticles safeguarded against ethanolic dose-dumping
US9855263B2 (en)2015-04-242018-01-02Grünenthal GmbHTamper-resistant dosage form with immediate release and resistance against solvent extraction
US10842750B2 (en)2015-09-102020-11-24Grünenthal GmbHProtecting oral overdose with abuse deterrent immediate release formulations

Similar Documents

PublicationPublication DateTitle
GB1147210A (en)Improvements in or relating to vitamins
US4529608A (en)Honey powder preserving its natural aroma components
GB1026493A (en)Dry,vitamin-active product and process for preparing same
EP0357169A1 (en)Stabilized vitamin powder
DE2105039B2 (en) Process for the production of microcapsules
US3714210A (en)Process for extracting full fat soybean flakes or meal
DE2812582A1 (en) PROCESS FOR THE PRODUCTION OF MICROCRYSTALLINE VITAMIN A ACETATE OR SUCH PREPARATIONS INCLUDED
JPS62265295A (en)Spray drying lactose product and its production
GB1426106A (en)Method of fixing lipophilic substances to starch or starch derivatives
US4911942A (en)Stabilized oil and fat powder
IE39730B1 (en)Process for the manufacture of a dry foodstuff powder containings fats,proteins and carbohydrates
US2554873A (en)Oat extract composition
ES401293A1 (en)Process of forming minute capsules and three-phase capsule-forming system useful in said process
ES393211A1 (en)Preparation of redispersible hydrophobic starch derivatives
US2834683A (en)Method of preparing cold water-soluble gelatin and the resulting product
GB490001A (en)Improvements in or relating to a vitamin product
US2533221A (en)Caramel color separation
US3674555A (en)Low density starch hydrolysates
GB996984A (en)Improvements in or relating to the extraction of edible proteins from oil-seed residues
US2940900A (en)Dry vitamine e composition
GB1072768A (en)Dessert composition mix and process for preparing same
GB1072795A (en)Solid composition containing fat-soluble vitamins and processes for making it
ES8605555A1 (en)Preparation process of aqueous, highly concentrated pressed cakes of solid materials.
SU528884A3 (en) Method for fractionating amylose mixture into high molecular weight and low molecular weight amylose
GB1086860A (en)Fibre recovery process

[8]ページ先頭

©2009-2025 Movatter.jp